364 related articles for article (PubMed ID: 17920540)
1. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce?
Savarin-Vuaillat C; Ransohoff RM
Neurotherapeutics; 2007 Oct; 4(4):590-601. PubMed ID: 17920540
[TBL] [Abstract][Full Text] [Related]
2. The Role of Selected Chemokines and Their Receptors in the Development of Gliomas.
Groblewska M; Litman-Zawadzka A; Mroczko B
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456359
[TBL] [Abstract][Full Text] [Related]
3. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.
Gouwy M; Struyf S; Leutenez L; Pörtner N; Sozzani S; Van Damme J
Immunobiology; 2014 Mar; 219(3):218-29. PubMed ID: 24268109
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and Challenges.
Sadeghian-Rizi T; Khanahmad H; Jahanian-Najafabadi A
CNS Neurol Disord Drug Targets; 2018; 17(7):496-508. PubMed ID: 30003862
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.
Liu C; Cui G; Zhu M; Kang X; Guo H
Int J Clin Exp Pathol; 2014; 7(12):8342-55. PubMed ID: 25674199
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
[TBL] [Abstract][Full Text] [Related]
8. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
9. Expression of chemokines and chemokine receptors during human renal transplant rejection.
Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.
Ghafouri-Fard S; Honarmand K; Taheri M
Metab Brain Dis; 2021 Mar; 36(3):375-406. PubMed ID: 33404937
[TBL] [Abstract][Full Text] [Related]
11. Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.
Matsui M; Weaver J; Proudfoot AE; Wujek JR; Wei T; Richer E; Trapp BD; Rao A; Ransohoff RM
J Neuroimmunol; 2002 Jul; 128(1-2):16-22. PubMed ID: 12098506
[TBL] [Abstract][Full Text] [Related]
12. The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases.
García-Cuesta EM; Santiago CA; Vallejo-Díaz J; Juarranz Y; Rodríguez-Frade JM; Mellado M
Front Endocrinol (Lausanne); 2019; 10():585. PubMed ID: 31507535
[TBL] [Abstract][Full Text] [Related]
13. Current status of chemokines in the adult CNS.
Réaux-Le Goazigo A; Van Steenwinckel J; Rostène W; Mélik Parsadaniantz S
Prog Neurobiol; 2013 May; 104():67-92. PubMed ID: 23454481
[TBL] [Abstract][Full Text] [Related]
14. Oxygen regulates human cytotrophoblast migration by controlling chemokine and receptor expression.
Schanz A; Red-Horse K; Hess AP; Baston-Büst DM; Heiss C; Krüssel JS
Placenta; 2014 Dec; 35(12):1089-94. PubMed ID: 25293376
[TBL] [Abstract][Full Text] [Related]
15. Interactions between chemokine and mu-opioid receptors: anatomical findings and electrophysiological studies in the rat periaqueductal grey.
Heinisch S; Palma J; Kirby LG
Brain Behav Immun; 2011 Feb; 25(2):360-72. PubMed ID: 20974247
[TBL] [Abstract][Full Text] [Related]
16. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors.
Honczarenko M; Le Y; Swierkowski M; Ghiran I; Glodek AM; Silberstein LE
Stem Cells; 2006 Apr; 24(4):1030-41. PubMed ID: 16253981
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4.
Hatse S; Princen K; Bridger G; De Clercq E; Schols D
FEBS Lett; 2002 Sep; 527(1-3):255-62. PubMed ID: 12220670
[TBL] [Abstract][Full Text] [Related]
18. The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy.
Zhou L; Ao L; Yan Y; Li W; Ye A; Hu Y; Fang W; Li Y
Curr Drug Targets; 2020; 21(3):288-301. PubMed ID: 31490748
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication by chemokines.
Gyoneva S; Ransohoff RM
Trends Pharmacol Sci; 2015 Jul; 36(7):471-80. PubMed ID: 25979813
[TBL] [Abstract][Full Text] [Related]
20. Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.
Strong AE; Thierry AC; Cousin P; Moulon C; Demotz S
Eur Cytokine Netw; 2006 Mar; 17(1):49-59. PubMed ID: 16613763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]